देश: इसराइल
भाषा: अंग्रेज़ी
स्रोत: Ministry of Health
SOLIFENACIN SUCCINATE
TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD
G04BD08
TABLETS
SOLIFENACIN SUCCINATE 10 MG
PER OS
Required
TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL
SOLIFENACIN
For symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome
2019-06-30
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor’s prescription only SOLIFENACIN-TRIMA 5 SOLIFENACIN-TRIMA 10 FILM-COATED TABLETS Each tablet of SOLIFENACIN-TRIMA 5 contains: Solifenacin succinate 5 mg Each tablet of SOLIFENACIN-TRIMA 10 contains: Solifenacin succinate 10 mg Inactive ingredients and allergens: see section 2 under ’Important information about some ingredients of the medicine’ and section 6 ‘Additional information’. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have any other questions, refer to the doctor or the pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if it seems to you that their medical condition is similar. DO NOT USE IN CHILDREN AND ADOLESCENTS UNDER THE AGE OF 18. 1. WHAT IS THE MEDICINE INTENDED FOR? This medicine is intended for the treatment of urinary incontinence and/ or conditions of increased urinary frequency and urgency in patients with overactive bladder. THERAPEUTIC CLASS: anticholinergic . BEFORE USING THE MEDICINE DO NOT USE THIS MEDICINE: If you are sensitive (allergic) to the active ingredient or to any of the additional ingredients the medicine contains. In case of urinary retention, severe gastrointestinal disorders (toxic megacolon), myasthenia gravis (severe muscle weakness), or intraocular pressure accompanied by decreased vision (glaucoma). In kidney patients undergoing dialysis and in patients with severe liver insufficiency. In patients with severe kidney disease or moderate liver disease who are being treated concomitantly with another medicine that decreases the removal of SOLIFENACIN-TRIMA from the body such as ketoconazole. SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE: BEFORE STARTING TREATMENT WITH SOLIFENACIN-TRIMA, INFORM YOUR DOCTOR IF: You have a problem passing urine (partial obstruction), you suffer from constipatio पूरा दस्तावेज़ पढ़ें